Next Quarterly Earnings
Thursday, March 11, 2027
Expected
Bachem Holding is a global leader in the development and manufacturing of peptides and oligonucleotides. As a partner to the pharmaceutical and biotech industry, Bachem provides specialized CDMO services and supports customers from research and development through to commercial production.
Bachem Holding last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.67 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.